AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Mitra, RS Benedict, MA Qian, DL Foreman, KE Ekhterae, D Nickoloff, BJ Nunez, G
Citation: Rs. Mitra et al., Killing of sarcoma cells by proapoptotic Bcl-X-S: Role of the BH3 domain and regulation by Bcl-X-L, NEOPLASIA, 3(5), 2001, pp. 437-445

Authors: Chen, B Stiff, P Sloan, G Kash, J Manjunath, R Pathasarathy, M Oldenburg, D Foreman, KE Nickoloff, BJ
Citation: B. Chen et al., Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli, CLIN IMMUNO, 98(2), 2001, pp. 280-292

Authors: Foreman, KE Nickoloff, BJ
Citation: Ke. Foreman et Bj. Nickoloff, Leukocyte adhesion and accessory molecules as therapeutic targets for inflammatory skin diseases, CELL ADHES, 8, 2001, pp. 251-262

Authors: Foreman, KE Friborg, J Chandran, B Katano, H Sata, T Mercader, M Nabel, GJ Nickoloff, BJ
Citation: Ke. Foreman et al., Injection of human herpesvirus-X in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions, J DERMA SCI, 26(3), 2001, pp. 182-193

Authors: Mercader, M Nickoloff, BJ Foreman, KE
Citation: M. Mercader et al., Induction of human immunodeficiency virus 1 replication by human herpesvirus 8, ARCH PATH L, 125(6), 2001, pp. 785-789

Authors: Taddeo, B Nickoloff, BJ Foreman, KE
Citation: B. Taddeo et al., Caspase inhibitor blocks human immunodeficiency virus 1-induced T-cell death without enhancement of HIV-1 replication and dimethyl sulfoxide increases HIV-1 replication without influencing T-cell survival, ARCH PATH L, 124(2), 2000, pp. 240-245

Authors: Mercader, M Taddeo, B Panella, JR Chandran, B Nickoloff, BJ Foreman, KE
Citation: M. Mercader et al., Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells, AM J PATH, 156(6), 2000, pp. 1961-1971

Authors: Foreman, KE Wrone-Smith, T Krueger, AE Nickoloff, BJ
Citation: Ke. Foreman et al., Expression of costimulatory molecules CD80 and or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation, CLIN IMMUNO, 91(3), 1999, pp. 345-353

Authors: Zong, JC Ciufo, DM Alcendor, DJ Wan, XY Nicholas, J Browning, PJ Rady, PL Tyring, SK Orenstein, JM Rabkin, CS Su, IJ Powell, KF Croxson, M Foreman, KE Nickoloff, BJ Alkan, S Hayward, GS
Citation: Jc. Zong et al., High-level variability in the ORF-K1 membrane protein gene at the left endof the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations, J VIROLOGY, 73(5), 1999, pp. 4156-4170

Authors: Mulligan, MS Warner, RL Rittershaus, CW Thomas, LJ Ryan, US Foreman, KE Crouch, LD Till, GO Ward, PA
Citation: Ms. Mulligan et al., Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewis(x) moieties, J IMMUNOL, 162(8), 1999, pp. 4952-4959
Risultati: 1-10 |